Sign In
Free Newsletter
Merck to cut 88 jobs at Rahway headquarters
Merck will eliminate 88 jobs at its Rahway headquarters as part of a multiyear restructuring and cost-cutting initiative.
Novartis cutting more jobs at East Hanover HQ (updated)
Swiss drugmaker Novartis will eliminate 76 jobs at its East Hanover headquarters as the company continues a global restructuring effort.
BioMarin cuts 58 jobs at Amicus HQ in Princeton
The layoffs at Amicus Therapeutics’ Princeton headquarters follow BioMarin's recent $4.8 billion acquisition of the biotech.
Bristol Myers Squibb launches ‘Won’t Lose’ World Cup campaign
The marketing push tied to the global event arriving this summer in N.J. and the U.S. more broadly highlights drug development, resilience and breakthrough medicines.
Merck completes $6.7B Terns acquisition
Merck completes its $6.7B Terns Pharmaceuticals acquisition, boosting its oncology pipeline with a new leukemia drug ahead of its Keytruda patent expiration.
FDA approves J&J’s Caplyta to prevent schizophrenia relapse
The FDA approved Johnson & Johnson’s Caplyta to prevent schizophrenia relapse, expanding its use after trial data showed reduced risk.
Novo Nordisk teams with OpenAI to speed drug development
Novo Nordisk and OpenAI partner to use AI for drug development, aiming to speed discovery, improve manufacturing and boost efficiency.
Johnson & Johnson highlights New Jersey roots, growth at Renew summit
Executive Vanessa Broadhurst detailed J&J's continued investments and role in the state economy as she introduced Gov. Mikie Sherrill during the ReNew summit in Atlantic City.
Cambrex advances $120M API plant expansion in Iowa
Cambrex advances its $120M expansion in Charles City, Iowa, boosting API manufacturing capacity and support complex pharmaceutical production.
FDA approves J&J pill Icotyde for plaque psoriasis
Johnson & Johnson’s treatment is the first once-daily oral medication for moderate-to-severe plaque psoriasis, offering an alternative to injections.
Bristol Myers Squibb discloses 247 more layoffs in NJ (updated)
The Lawrenceville-based pharmaceutical giant will eliminate 247 positions in New Jersey as part of a $2B cost-cutting plan tied to a restructuring initiative.
Novo Nordisk’s Wegovy weight loss pill hits US market
The pharma launched a once-daily alternative to its injections, available nationwide after FDA approval at 70,000 pharmacies with starting doses priced at $149 per month.
